Effects of JL 3, a putative antidepressant, on rat noradrenergic and serotonergic systems

European Journal of Pharmacology

Volumn 386, Issue 2-3, 1999, Pages 211-216

  Liégeois, Jean François ^a   Seutin, Vincent ^a   Scuvée Moreau, Jacqueline ^a   Dresse, Albert ^a   Bruhwyler, Jacques ^b   Géczy, Joseph ^b   Delarge, Jacques ^a   Damas, Jacques ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Therabel Pharma Belgium   (Belgium)

Author keywords

2 Adrenoceptor; 5 HT(1A) receptor; Antidepressant; Electrophysiology; Norepinephrine transporter; Pyridobenzoazepine; Tyramine

Indexed keywords

10 (4 METHYLPIPERAZIN 1 YL)PYRIDO[4,3 B][1,4]BENZOTHIAZEPINE; ALPHA 2 ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RITANSERIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; TYRAMINE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG BINDING SITE; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; MALE; NERVE CELL INHIBITION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SEROTONINERGIC SYSTEM;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS; DRUG INTERACTIONS; LOCUS COERULEUS; MALE; NEURONS; NOREPINEPHRINE; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; RECEPTORS, SEROTONIN; THIAZEPINES; TYRAMINE;

EID: 0343775811     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00777-3     Document Type: Article

References (24)

1. Aghajanian G.K., Foote W.E., Sheard M.H. Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science. 161:1968;706-708.
2. Anderson C.D., Pasquier D.A., Forbes W.B., Morgane P.J. Locus coeruleus to dorsal raphe input examined by electrophysiological and morphological methods. Brain Res. 2:1977;209-221.
3. Baraban J.M., Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology. 19:1980;355-363.
4. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse. 1:1987;470-480.
5. Bruhwyler J., Liégeois J.-F., Chleide E., Rogister F., Damas J., Delarge J., Mercier M. New dibenzoazepine derivatives with disinhibitory/anxiolytic and/or antidepressant potential: behavioural study in the open-field and forced swimming tests. Behav. Pharmacol. 3:1995;567-579.
6. 2 receptors. Eur. J. Pharmacol. 154:1988;285-291.
7. Guimaraes S., Trendelenburg U. Deviation and supersensitivity and inhibition of saturable site of loss. TiPS. 6:1985;371-374.
8. Haddjeri N., de Montigny C., Blier P. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxytryptamine system. Br. J. Pharmacol. 120:1997;865-875.
9. Iversen L.L. Drugs which affect the storage of noradrenaline. The actions of sympathomimetic amines. The Uptake and Storage of Noradrenaline in Sympathetic Nerves. 1967;181-186 Cambridge Univ. Press, Cambridge.
10. Liégeois J.-F., Rogister F., Bruhwyler J., Damas J., Nguyen T.P., Inarejos M.O., Chleide E., Mercier M., Delarge J. Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potent central nervous system agents: synthesis and neurochemical study. J. Med. Chem. 37:1994;519-525.
11. Liégeois J.-F., Scuvée-Moreau J., Giesberg I., Damas J., Bruhwyler J., Géczy J., Delarge J., Dresse A. Dibenzoazepine analogues: the electrophysiological properties of JL 3, a potential atypical antidepressant. Eur. J. Pharmacol. 310:1996;9-12.
12. Marwaha J., Aghajanian G.K. Relative potencies of alpha-1 and alpha-2 antagonists in the locus coeruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J. Pharmacol. Exp. Ther. 222:1982;287-293.
13. 1-adrenoceptors in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 317:1981;273-275.
14. Quinaux N., Scuvée-Moreau J., Dresse A. Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; correlation with reduction of spontaneous firing rate of central monoaminergic neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 319:1982;66-70.
15. Schotte A., Janssen P.F.M., Gommeren W., Luyten W.H.M.L., VanGompel P., Lesage A.S., DeLoore K., Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology. 124:1996;57-73.
16. Scuvée-Moreau J., Dresse A. Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. Eur. J. Pharmacol. 57:1979;219-225.
17. Seutin V., Scuvée-Moreau J., Giesbers I., Massotte L., Dresse A. Effect of BHT920 on monoaminergic neurons of the rat brain: an electrophysiological in vivo and in vitro study. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;502-507.
18. 1A selective agonists. Eur. J. Pharmacol. 128:1986;295-298.
19. 1B agonists. Synapse. 1:1987;3-9.
20. Svensson T.H., Bunney B.S., Aghajanian G.K. Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res. 92:1975;291-306.
21. VanderMaelen C.P., Braselton J.P. Effects of a potential antipsychotic, BMY 14802, on firing of central serotonergic and noradrenergic neurons in rats. Eur. J. Pharmacol. 179:1990;357-366.
22. VanderMaelen C.P., Matheson G.K., Wilderman R.C., Patterson L.A. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur. J. Pharmacol. 129:1986;123-130.
23. 1A subtype. Eur. J. Pharmacol. 113:1985;463-464.
24. 1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem. Int. 7:1985;1061.